Aqueous Conversion Kinetics and Mechanisms of Ancitabine, a Prodrug of the Antileukemic Agent Cytarabine
- 1 July 1984
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 73 (7) , 896-902
- https://doi.org/10.1002/jps.2600730709
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prodrug designPharmacology & Therapeutics, 1981
- A Rapid Stability-Indicating HPLC Assay for the Arabinosylcytosine Prodrug, CyclocytidineJournal of Liquid Chromatography, 1981
- Mathematical Model for Cyclocytidine PharmacokineticsJournal of Pharmaceutical Sciences, 1977
- Clinical pharmacology of O2,2'‐cyclocytidineClinical Pharmacology & Therapeutics, 1975
- Metabolites of 5-3H-cyclocytidine in monkeys given single intravenous injection.CHEMICAL & PHARMACEUTICAL BULLETIN, 1975
- Metabolism of cyclocytidine and aracytidine in mice.CHEMICAL & PHARMACEUTICAL BULLETIN, 1975
- Biochemical studies of a new antitumor agent, O2,2′-cyclocytidineBiochemical Pharmacology, 1974
- Resistance of Cyclocytidine to Cytidine DeaminaseCHEMICAL & PHARMACEUTICAL BULLETIN, 1973
- Arabinosylcytosine Stability in Aqueous Solutions: pH Profile and Shelflife PredictionsJournal of Pharmaceutical Sciences, 1972
- Kinetic Salt Effect in Pharmaceutical InvestigationsJournal of Pharmaceutical Sciences, 1970